Keeping dreams alive
A new way of treating disease, stem cell immunology
StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells.
We seek to make a difference in patient’s lives. Bringing new beginnings to the market by developing novel therapeutics.
StemVax has partnered with Softlayer an IBM company, Softlayer.com